Global EPA / DHA/ALA (Omega 3) Market Research Report 2021

1 EPA / DHA/ALA (Omega 3) Market Overview

• 1.1 Product Overview and Scope of EPA / DHA/ALA (Omega 3)
• 1.2 EPA / DHA/ALA (Omega 3) Segment by Type
  • 1.2.1 Global EPA / DHA/ALA (Omega 3) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Fish Oil
  • 1.2.3 Algae Oil
• 1.3 EPA / DHA/ALA (Omega 3) Segment by Application
  • 1.3.1 EPA / DHA/ALA (Omega 3) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Dietary Supplements
  • 1.3.3 Functional Foods & Beverages
  • 1.3.4 Others
• 1.4 Global EPA / DHA/ALA (Omega 3) Market Size Estimates and Forecasts
  • 1.4.1 Global EPA / DHA/ALA (Omega 3) Revenue 2016-2027
  • 1.4.2 Global EPA / DHA/ALA (Omega 3) Sales 2016-2027
  • 1.4.3 EPA / DHA/ALA (Omega 3) Market Size by Region: 2016 Versus 2021 Versus 2027

2 EPA / DHA/ALA (Omega 3) Market Competition by Manufacturers

• 2.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global EPA / DHA/ALA (Omega 3) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers EPA / DHA/ALA (Omega 3) Manufacturing Sites, Area Served, Product Type
• 2.5 EPA / DHA/ALA (Omega 3) Market Competitive Situation and Trends
  • 2.5.1 EPA / DHA/ALA (Omega 3) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest EPA / DHA/ALA (Omega 3) Players Market Share by Revenue
  • 2.5.3 Global EPA / DHA/ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 EPA / DHA/ALA (Omega 3) Retrospective Market Scenario by Region

• 3.1 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
  • 3.3.1 North America EPA / DHA/ALA (Omega 3) Sales by Country
  • 3.3.2 North America EPA / DHA/ALA (Omega 3) Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
  • 3.4.1 Europe EPA / DHA/ALA (Omega 3) Sales by Country
  • 3.4.2 Europe EPA / DHA/ALA (Omega 3) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific EPA / DHA/ALA (Omega 3) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region
  • 3.5.2 Asia Pacific EPA / DHA/ALA (Omega 3) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
  • 3.6.1 Latin America EPA / DHA/ALA (Omega 3) Sales by Country
  • 3.6.2 Latin America EPA / DHA/ALA (Omega 3) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country
  • 3.7.2 Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Type

• 4.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2021)
• 4.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Type (2016-2021)
• 4.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2021)

5 Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Application

• 5.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2021)
• 5.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2016-2021)
• 5.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 EPAX
  • 6.1.1 EPAX Corporation Information
  • 6.1.2 EPAX Description and Business Overview
  • 6.1.3 EPAX EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 EPAX Product Portfolio
  • 6.1.5 EPAX Recent Developments/Updates
• 6.2 Golden Omega
  • 6.2.1 Golden Omega Corporation Information
  • 6.2.2 Golden Omega Description and Business Overview
  • 6.2.3 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Golden Omega Product Portfolio
  • 6.2.5 Golden Omega Recent Developments/Updates
• 6.3 TASA
  • 6.3.1 TASA Corporation Information
  • 6.3.2 TASA Description and Business Overview
  • 6.3.3 TASA EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 TASA Product Portfolio
  • 6.3.5 TASA Recent Developments/Updates
• 6.4 Omega Protein
  • 6.4.1 Omega Protein Corporation Information
  • 6.4.2 Omega Protein Description and Business Overview
  • 6.4.3 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Omega Protein Product Portfolio
  • 6.4.5 Omega Protein Recent Developments/Updates
• 6.5 Croda
  • 6.5.1 Croda Corporation Information
  • 6.5.2 Croda Description and Business Overview
  • 6.5.3 Croda EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Croda Product Portfolio
  • 6.5.5 Croda Recent Developments/Updates
• 6.6 KD Pharma
  • 6.6.1 KD Pharma Corporation Information
  • 6.6.2 KD Pharma Description and Business Overview
  • 6.6.3 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 KD Pharma Product Portfolio
  • 6.6.5 KD Pharma Recent Developments/Updates
• 6.7 GC Rieber
  • 6.6.1 GC Rieber Corporation Information
  • 6.6.2 GC Rieber Description and Business Overview
  • 6.6.3 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 GC Rieber Product Portfolio
  • 6.7.5 GC Rieber Recent Developments/Updates
• 6.8 Polaris
  • 6.8.1 Polaris Corporation Information
  • 6.8.2 Polaris Description and Business Overview
  • 6.8.3 Polaris EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Polaris Product Portfolio
  • 6.8.5 Polaris Recent Developments/Updates
• 6.9 Auqi
  • 6.9.1 Auqi Corporation Information
  • 6.9.2 Auqi Description and Business Overview
  • 6.9.3 Auqi EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Auqi Product Portfolio
  • 6.9.5 Auqi Recent Developments/Updates

7 EPA / DHA/ALA (Omega 3) Manufacturing Cost Analysis

• 7.1 EPA / DHA/ALA (Omega 3) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of EPA / DHA/ALA (Omega 3)
• 7.4 EPA / DHA/ALA (Omega 3) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 EPA / DHA/ALA (Omega 3) Distributors List
• 8.3 EPA / DHA/ALA (Omega 3) Customers

9 EPA / DHA/ALA (Omega 3) Market Dynamics

• 9.1 EPA / DHA/ALA (Omega 3) Industry Trends
• 9.2 EPA / DHA/ALA (Omega 3) Growth Drivers
• 9.3 EPA / DHA/ALA (Omega 3) Market Challenges
• 9.4 EPA / DHA/ALA (Omega 3) Market Restraints

10 Global Market Forecast

• 10.1 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Type (2022-2027)
• 10.2 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Application (2022-2027)
• 10.3 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List